- Home
- SCTX vs NXRT Comparison
SCTX vs NXRT Comparison
Compare SCTX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCTX | NXRT |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 582.3M |
| IPO Year | 2026 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SCTX | NXRT |
|---|---|---|
| Price | $17.20 | $19.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $57.00 | $28.50 |
| AVG Volume (30 Days) | 271.3K | ★ 613.0K |
| Earning Date | 09-02-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 10.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $251,281,000.00 |
| Revenue This Year | N/A | $2.06 |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.31 | $19.09 |
| 52 Week High | $39.60 | $32.36 |
Technical Indicators
Market Signals| Indicator | SCTX | NXRT |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 25.60 |
| Support Level | N/A | N/A |
| Resistance Level | $26.50 | $24.77 |
| Average True Range (ATR) | 3.71 | 0.68 |
| MACD | -1.36 | -0.14 |
| Stochastic Oscillator | 4.94 | 6.98 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.